AstraZeneca Reports Strong Q2 Earnings Surge and Strategic Regulatory Wins
AstraZeneca PLC reports a 11.7% surge in revenue to $14.457 billion in Q2 2025, driven by strategic collaborations and regulatory milestones in its oncology, cardiovascular, and respiratory therapeutic areas.
2 minutes to read


